H. Makino, T. Saijo, Y. Ashida, H. Kuriki and Y. Maki, “Mechanism of Action of an Antiallergic Agent, Am- lexanox (AA-673), in Inhibiting Histamine Release from Mast Cells,” International Archives of Allergy and Immunology, Vol. 82, No. 1, 1987, pp. 66-71. doi:org/10.1159/000234292
 C. Scully and S. Porter, “Oral mucosal disease: Recurrent aphthous stomatitis,” British Journal of Oral and Maxil-lofacial Surgery, Vol. 46, No. 3, 2008, pp. 198-206. doi:org/10.1016/j.bjoms.2007.07.201
 J. Liu, X. Zeng, Q. Chen, Y. Cai, F. Chen , Y. Wang, H. Zhou, M. Lin, J. Shi, Z. Wang and Y. Zhang, “An Evaluation on the Efficacy and Safety of Amlexanox Oral Adhesive Tablets in the Treatment of Recurrent Minor Aphthous Ulceration in a Chinese Cohort: A Randomized, Double-Blind, Vehicle-Controlled, Unparallel Multicenter Clinical Trial,” Oral Surgery Oral Medicine Oral Pa-Thologz Oral Radiology and Endodontology, Vol. 102, No. 4, 2006, pp. 475-481.
 S. McComish, A. Mize, J. Harris, N. Premkumar and L. E. Colon, “A High-Pressure Liquid Chromatographic Method for Measuring Mitotane: [1,1-(o,p-Dichlorodiphenyl)-2,2- Dichloroethane] and Its Metabolite 1,1-(o,p'-Dichlorodi- phenyl)-2,2-dichloroethene in Plasma,” Therapeutic Drug Monitoring, Vol. 17, No. 5, 1995, pp. 526-531. doi:org/10.1097/00007691-199510000-00015
 A. Khandwala, R. G. V. Inwegen and M. C. Alfano, “5% Amlexanox Oral Paste, a New Treatment for Recurrent Minor Aphthous Ulcers: I. Clinical Demonstration of Acceleration of Healing and Resolution of Pain,” Oral Surgery Oral Medicine Oral Pathologz Oral Radiology and Endodontology, Vol. 83, No. 2, 1997, pp. 222- 230.
 A. Khandwala, R. G. V. Inwegen, M. R. Charney and M. C. Alfano, “5% Amlexanox Oral Paste, a New Treatment for Recurrent Minor Aphthous Ulcers II: Pharmacokinetics and Demonstration of Clinical Safety,” Oral Surgery Oral Medicine Oral Pathologz Oral Radiology and Endodon- tology, Vol. 83, No. 2, 1997, pp. 231-238.
 International Federation of Pharmaceutical Manufactures & Associations, “ICH Stability Testing of New Drug Substances and Products Q1A (R2),” International Con-ference on Harmonization, Geneva, 2003.
 M. Bakshi and S. Singh, “Development of Validated Stability-Indicating Assay Methods-Critical Review,” Journal of Pharmaceutical and Biomedical Analysis, Vol. 28, No. 6, 2002, pp. 1011-1040. doi:org/10.1016/S0731-7085(02)00047-X